Cargando…
Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes
OBJECTIVE: Whey protein (WP) intake has been shown to reduce postprandial glycemia. Majority of WP research in type 2 diabetes (T2DM) involved acute challenge or weight loss studies. It is not known if WP supplementation can provide sustained glucose lowering. Our goal was to investigate the effects...
Autores principales: | Almario, Rogelio U, Buchan, Wendy M, Rocke, David M, Karakas, Sidika E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530249/ https://www.ncbi.nlm.nih.gov/pubmed/28761664 http://dx.doi.org/10.1136/bmjdrc-2017-000420 |
Ejemplares similares
-
Corrections: Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes
Publicado: (2017) -
Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
por: Moonira, Tabassum, et al.
Publicado: (2020) -
ODP246 The Content of Blood Chemokine Fractalkine in Patients with Type 2 Diabetes and Diabetic Macular Edema Depending on The Type of Glucose Lowering Therapy
por: Kyryliuk, Mykhailo, et al.
Publicado: (2022) -
Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
por: Christensen, Mikkel, et al.
Publicado: (2011) -
Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
por: Karakas, Sidika E., et al.
Publicado: (2010)